Case report · 15 Feb 2025
EditorialPublished 30 Apr 2021
Lung Carcinoma Disorders
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung carcinoma is the main source of disease related passing around the world. About 85% of cases are identified with cigarette smoking. Manifestations can incorporate hack, chest distress or agony, weight reduction, and, less usually, hemoptysis; be that as it may, numerous patients present with metastatic illness with or with no clinical indications. The conclusion is regularly made by chest xbeam or CT and affirmed by biopsy. Contingent upon the phase of the sickness, therapy incorporates a medical procedure, chemotherapy, radiation treatment, or a blend. For as long as a very long while, the anticipation for a cellular breakdown in the lungs patient was poor, with just 15% of patients enduring > a long time from the hour of analysis. For patients with stage IV (metastatic) sickness, the 5-year generally speaking endurance rate was < 1%. Nonetheless, results have improved on account of the ID of specific changes that can be focused for treatment and current 5-year endurance rates are 19% (23% for ladies and 16% for men). The manifestations of cellular breakdown in the lungs rely upon its sort, its area, and the manner in which it spreads inside the lungs, to zones close to the lungs, or somewhere else in the body
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 29 Apr 2024
Acute Motor Sensory Axonal Neuropathy (AMSAN), a variant of Guillain Barré syndrome in a patient of Non-small cell Lung Carcinoma- A Case Report.
Perspective · 29 Mar 2024
Knowing Causes, Diagnosis, and Treatment Options for Lung Carcinoma
Opinion · 18 Sep 2023
Metastasis of Hepatocellular Carcinoma to the Lungs and Virchow Center Developments
Case report · 31 May 2023
A Case Study on Two Primary Cancer of Non-Hodgkin's Lymphoma Together with Lung Squamous Cell Carcinoma
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Thomas Kalhor”

